Table 2.
Incidence of initial symptoms and laboratory tests in Chinese cohort with postoperative duodenal adenocarcinoma.
| Variable | Patient demographics (%) |
|---|---|
| Symptom at diagnosis | |
| Alimentray symptoms | 90 (65.7%) |
| Abdominal pain | 53 (38.7%) |
| Nausea and vomiting | 25 (18.2%) |
| Gastrointestional bleeding | 12 (8.8%) |
| Jaundice | 32 (23.4%) |
| Itching | 11 (8.0%) |
| Asymoptomatic | 8 (5.8%) |
| Others* | 34 (24.8%) |
| CEA | |
| Normal | 70 (67.2%) |
| High | 18 (13.1%) |
| Inconclusion | 27 (19.7%) |
| CA19–9 | |
| Normal | 70 (51.1%) |
| High | 40 (29.2%) |
| Inconclusion | 27 (19.7%) |
Abbreviations: CEA, carcinoembryonic antigen; CA19–9, carbohydrate antigen 19–9; Others* included weight loss, fatigue and fever.